Antidepressants inhibit P2X4 receptor function: A possible involvement in neuropathic pain relief

Molecular Pain

Volumn 5, Issue , 2009, Pages

  Nagata, Kenichiro ^a   Imai, Toshiyasu ^a   Yamashita, Tomohiro ^a   Tsuda, Makoto ^a   Tozaki Saitoh, Hidetoshi ^a   Inoue, Kazuhide ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

5,7 DIHYDROXYTRYPTAMINE; ADENOSINE TRIPHOSPHATE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CALCIUM ION; CARBAMAZEPINE; CITALOPRAM; CLOMIPRAMINE; DESIPRAMINE; DOXEPIN; FLUOXETINE; FLUVOXAMINE; GABAPENTIN; IMIPRAMINE; KETANSERIN; MAPROTILINE; MIANSERIN; MILNACIPRAN; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; NORTRIPTYLINE; ONDANSETRON; PAROXETINE; PURINERGIC P2X4 RECEPTOR; SEROTONIN; SEROTONIN TRANSPORTER; ZONISAMIDE; PURINERGIC P2 RECEPTOR; SEROTONIN ANTAGONIST;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM SIGNALING; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE MODEL; DRUG POTENCY; IC 50; INHIBITION KINETICS; MALE; NEUROPATHIC PAIN; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; SEROTONIN RELEASE; ACTION POTENTIAL; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; INTRASPINAL DRUG ADMINISTRATION; METABOLISM; PAIN; PAIN ASSESSMENT; PATHOLOGY; SPINAL CORD; TUMOR CELL LINE; WISTAR RAT;

ACTION POTENTIALS; ANIMALS; ANTIDEPRESSIVE AGENTS; CELL LINE, TUMOR; CITALOPRAM; DISEASE MODELS, ANIMAL; FLUVOXAMINE; HUMANS; INJECTIONS, SPINAL; MALE; PAIN; PAIN MEASUREMENT; PAROXETINE; RATS; RATS, WISTAR; RECEPTORS, PURINERGIC P2; SEROTONIN ANTAGONISTS; SPINAL CORD;

EID: 65649111683     PISSN: 17448069     EISSN: None     Source Type: Journal    
DOI: 10.1186/1744-8069-5-20     Document Type: Article

References (52)

1. Sindrup SH Otto M Finnerup NB Jensen TS Antidepressants in the treatment of neuropathic pain Basic Clin Pharmacol Toxicol 2005, 96:399-409. 10.1111/j.1742-7843.2005.pto_96696601.x 15910402
2. Lynch ME Antidepressants as analgesics: A review of randomized controlled trials J Psychiatry Neurosci 2001, 26:30-36. 1408040 11212591
3. Max MB Culnane M Schafer SC Gracely RH Walther DJ Smoller B Dubner R Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood Neurology 1987, 37:589-596. 2436092
4. Kvinesdal B Molin J Froland A Gram LF Imipramine treatment of painful diabetic neuropathy Jama 1984, 251:1727-1730. 10.1001/jama.251.13.1727 6366276
5. Sindrup SH Gram LF Skjold T Grodum E Brosen K Beck-Nielsen H Clomipramine vs desipramine vs placebo in the treatment of diabetic neuropathy symptoms. A double-blind cross-over study Br J Clin Pharmacol 1990, 30:683-691. 1368167 2271367
6. Max MB Kishore-Kumar R Schafer SC Meister B Gracely RH Smoller B Dubner R Efficacy of desipramine in painful diabetic neuropathy: A placebo-controlled trial Pain 1991, 45:3-9. discussion 1-2 10.1016/ 0304-3959(91)90157-S 1861872
7. Sindrup SH Tuxen C Gram LF Grodum E Skjold T Brosen K Beck-Nielsen H Lack of effect of mianserin on the symptoms of diabetic neuropathy Eur J Clin Pharmacol 1992, 43:251-255. 10.1007/BF02333018 1425887
8. Watson CP Evans RJ Reed K Merskey H Goldsmith L Warsh J Amitriptyline versus placebo in postherpetic neuralgia Neurology 1982, 32:671-673. 6283422
9. Max MB Schafer SC Culnane M Smoller B Dubner R Gracely RH Amitriptyline, but not lorazepam, relieves postherpetic neuralgia Neurology 1988, 38:1427-1432. 3412591
10. Kishore-Kumar R Max MB Schafer SC Gaughan AM Smoller B Gracely RH Dubner R Desipramine relieves postherpetic neuralgia Clin Pharmacol Ther 1990, 47:305-312. 2178851
11. Raja SN Haythornthwaite JA Pappagallo M Clark MR Travison TG Sabeen S Royall RM Max MB Opioids versus antidepressants in postherpetic neuralgia: A randomized, placebo-controlled trial Neurology 2002, 59:1015-1021. 12370455
12. Max MB Lynch SA Muir J Shoaf SE Smoller B Dubner R Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy N Engl J Med 1992, 326:1250-1256. 1560801
13. Jackson KC 2nd Pharmacotherapy for neuropathic pain Pain Pract 2006, 6:27-33. 10.1111/j.1533-2500.2006.00055.x 17309706
14. Sindrup SH Gram LF Brosen K Eshoj O Mogensen EF The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms Pain 1990, 42:135-144. 10.1016/0304-3959(90)91157-E 2147235
15. Baldessarini RJ Drug therapy of depression and anxiety disorders 11 2006.
16. Reynolds IJ Miller RJ Tricyclic antidepressants block N-methyl-D-aspartate receptors: Similarities to the action of zinc Br J Pharmacol 1988, 95:95-102. 1854115 2905906
17. Watanabe Y Saito H Abe K Tricyclic antidepressants block NMDA receptor-mediated synaptic responses and induction of long-term potentiation in rat hippocampal slices Neuropharmacology 1993, 32:479-486. 10.1016/0028-3908(93)90173-Z 8321429
18. Hall H Ogren SO Effects of antidepressant drugs on different receptors in the brain Eur J Pharmacol 1981, 70:393-407. 10.1016/ 0014-2999(81)90172-2 6262100
19. Amir R Argoff CE Bennett GJ Cummins TR Durieux ME Gerner P Gold MS Porreca F Strichartz GR The role of sodium channels in chronic inflammatory and neuropathic pain J Pain 2006, 7:S1-29. 10.1016/ j.jpain.2006.01.444 16632328
20. Dick IE Brochu RM Purohit Y Kaczorowski GJ Martin WJ Priest BT Sodium Channel Blockade May Contribute to the Analgesic Efficacy of Antidepressants J Pain 2007, 8(4):315-24. Epub 2006 Dec 15 10.1016/ j.jpain.2006.10.001 17175203
21. Huang CJ Harootunian A Maher MP Quan C Raj CD McCormack K Numann R Negulescu PA Gonzalez JE Characterization of voltage-gated sodium-channel blockers by electrical stimulation and fluorescence detection of membrane potential Nat Biotechnol 2006, 24:439-446. 10.1038/ nbt1194 16550174
22. Traboulsie A Chemin J Kupfer E Nargeot J Lory P T-type calcium channels are inhibited by fluoxetine and its metabolite norfluoxetine Mol Pharmacol 2006, 69:1963-1968. 10.1124/mol.105.020842 16510561
23. Ishii Y Sumi T Amitriptyline inhibits striatal efflux of neurotransmitters via blockade of voltage-dependent Na+ channels Eur J Pharmacol 1992, 221:377-380. 10.1016/0014-2999(92)90726-K 1358657
24. Tsuda M Shigemoto-Mogami Y Koizumi S Mizokoshi A Kohsaka S Salter MW Inoue K P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury Nature 2003, 424:778-783. 10.1038/ nature01786 12917686
25. Marlier L Teilhac JR Cerruti C Privat A Autoradiographic mapping of 5-HT1, 5-HT1A, 5-HT1B and 5-HT2 receptors in the rat spinal cord Brain Res 1991, 550:15-23. 10.1016/0006-8993(91)90400-P 1832328
26. Hamon M Gallissot MC Menard F Gozlan H Bourgoin S Verge D 5-HT3 receptor binding sites are on capsaicin-sensitive fibres in the rat spinal cord Eur J Pharmacol 1989, 164:315-322. 10.1016/0014-2999(89)90472-X 2759179
27. Thor KB Nickolaus S Helke CJ Autoradiographic localization of 5-hydroxytryptamine1A, 5-hydroxytryptamine1B and 5-hydroxytryptamine1C/2 binding sites in the rat spinal cord Neuroscience 1993, 55:235-252. 10.1016/0306-4522(93)90469-V 8350989
28. Bianchi BR Lynch KJ Touma E Niforatos W Burgard EC Alexander KM Park HS Yu H Metzger R Kowaluk E, et al Pharmacological characterization of recombinant human and rat P2X receptor subtypes Eur J Pharmacol 1999, 376:127-138. 10.1016/S0014-2999(99)00350-7 10440098
29. Gallagher CJ Salter MW Differential properties of astrocyte calcium waves mediated by P2Y1 and P2Y2 receptors J Neurosci 2003, 23:6728-6739. 12890765
30. Townsend-Nicholson A King BF Wildman SS Burnstock G Molecular cloning, functional characterization and possible cooperativity between the murine P2X4 and P2X4a receptors Brain Res Mol Brain Res 1999, 64:246-254. 10.1016/S0169-328X(98)00328-3 9931497
31. Jones CA Chessell IP Simon J Barnard EA Miller KJ Michel AD Humphrey PP Functional characterization of the P2X(4) receptor orthologues Br J Pharmacol 2000, 129:388-394. 1571843 10694247 10.1038/sj.bjp.0703059
32. Khakh BS Burnstock G Kennedy C King BF North RA Seguela P Voigt M Humphrey PP International union of pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits Pharmacol Rev 2001, 53:107-118. 11171941
33. Nasu-Tada K Koizumi S Tsuda M Kunifusa E Inoue K Possible involvement of increase in spinal fibronectin following peripheral nerve injury in upregulation of microglial P2X4, a key molecule for mechanical allodynia Glia 2006, 53:769-775. 10.1002/glia.20339 16534777
34. Uhr M Grauer MT Holsboer F Differential enhancement of antidepressant penetration into the brain in mice with abcb1ab (mdr1ab) P-glycoprotein gene disruption Biol Psychiatry 2003, 54:840-846. 10.1016/ S0006-3223(03)00074-X 14550684
35. Benjamin ER Pruthi F Olanrewaju S Shan S Hanway D Liu X Cerne R Lavery D Valenzano KJ Woodward RM Ilyin VI Pharmacological characterization of recombinant N-type calcium channel (Cav2.2) mediated calcium mobilization using FLIPR Biochem Pharmacol 2006, 72:770-782. 10.1016/ j.bcp.2006.06.003 16844100
36. Yeung SY Millar JA Mathie A Inhibition of neuronal KV potassium currents by the antidepressant drug, fluoxetine Br J Pharmacol 1999, 128:1609-1615. 1571791 10602343 10.1038/sj.bjp.0702955
37. Chou CT He S Jan CR Paroxetine-induced apoptosis in human osteosarcoma cells: Activation of p38 MAP kinase and caspase-3 pathways without involvement of [Ca2+]i elevation Toxicol Appl Pharmacol 2007, 218:265-273. 10.1016/j.taap.2006.11.012 17174998
38. Sindrup SH Bjerre U Dejgaard A Brosen K Aaes-Jorgensen T Gram LF The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy Clin Pharmacol Ther 1992, 52:547-552. 1424428
39. Tsuda M Inoue K Salter MW Neuropathic pain and spinal microglia: A big problem from molecules in "small" glia Trends Neurosci 2005, 28:101-107. 10.1016/j.tins.2004.12.002 15667933
40. Bardin L Bardin M Lavarenne J Eschalier A Effect of intrathecal serotonin on nociception in rats: Influence of the pain test used Exp Brain Res 1997, 113:81-87. 10.1007/BF02454144 9028777
41. Crisp T Stafinsky JL Spanos LJ Uram M Perni VC Donepudi HB Analgesic effects of serotonin and receptor-selective serotonin agonists in the rat spinal cord Gen Pharmacol 1991, 22:247-251. 1829046
42. Jeong CY Choi JI Yoon MH Roles of serotonin receptor subtypes for the antinociception of 5-HT in the spinal cord of rats Eur J Pharmacol 2004, 502:205-211. 10.1016/j.ejphar.2004.08.048 15476746
43. Deseure K Breand S Colpaert FC Curative-like analgesia in a neuropathic pain model: Parametric analysis of the dose and the duration of treatment with a high-efficacy 5-HT(1A) receptor agonist Eur J Pharmacol 2007, 568(1-3):134-41. Epub 2007 Apr 22 10.1016/j.ejphar.2007.04.022 17512927
44. Sasaki M Obata H Saito S Goto F Antinociception with intrathecal alpha-methyl-5-hydroxytryptamine, a 5-hydroxytryptamine 2A/2C receptor agonist, in two rat models of sustained pain Anesth Analg 2003, 96:1072-1078. table of contents 10.1213/01.ANE.0000050560.15341.A8 12651663
45. Oatway MA Chen Y Weaver LC The 5-HT3 receptor facilitates at-level mechanical allodynia following spinal cord injury Pain 2004, 110:259-268. 10.1016/j.pain.2004.03.040 15275776
46. Bardin L Schmidt J Alloui A Eschalier A Effect of intrathecal administration of serotonin in chronic pain models in rats Eur J Pharmacol 2000, 409:37-43. 10.1016/S0014-2999(00)00796-2 11099698
47. Sawynok J Reid A Spinal supersensitivity to 5-HT1, 5-HT2 and 5-HT3 receptor agonists following 5,7-dihydroxytryptamine Eur J Pharmacol 1994, 264:249-257. 10.1016/0014-2999(94)00465-X 7698162
48. Wang CZ Namba N Gonoi T Inagaki N Seino S Cloning and pharmacological characterization of a fourth P2X receptor subtype widely expressed in brain and peripheral tissues including various endocrine tissues Biochem Biophys Res Commun 1996, 220:196-202. 10.1006/bbrc.1996.0380 8602843
49. Kim SH Chung JM An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat Pain 1992, 50:355-363. 10.1016/0304-3959(92)90041-9 1333581
50. Dixon WJ Efficient analysis of experimental observations Annu Rev Pharmacol Toxicol 1980, 20:441-462. 10.1146/annurev.pa.20.040180.002301 7387124
51. Chaplan SR Bach FW Pogrel JW Chung JM Yaksh TL Quantitative assessment of tactile allodynia in the rat paw J Neurosci Methods 1994, 53:55-63. 10.1016/0165-0270(94)90144-9 7990513
52. Yaksh TL Jessell TM Gamse R Mudge AW Leeman SE Intrathecal morphine inhibits substance P release from mammalian spinal cord in vivo Nature 1980, 286:155-157. 10.1038/286155a0 6157098